Regulatory Affairs services play a vital role in ensuring the successful development and commercialization of drugs as they navigate the complex and ever-changing landscape of global health authorities. Ensuring compliance throughout the process is a mandatory requirement. To overlook the procedures across the product life cycle, organizations deploy proven experts for Regulatory Affairs services and consulting. The expert team acts as a crucial link between the organization and global Health Authorities, tracking all the key regulations related to the product and prerequisites for its launch. In the current situation, not many organizations have the privilege of having these teams in-house, given their dedicated focus and approach toward innovation and drug safety.